Lv1
40 积分 2024-02-21 加入
Safety and Efficacy of Methotrexate for Chinese Adults With Psoriasis With and Without Psoriatic Arthritis
5天前
已完结
Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial
13天前
已完结
Systemic therapy in treating palmoplantar and scalp psoriasis: A systematic review and network meta-analysis
14天前
已完结
Efficacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Psoriasis and Special Body Area Involvement: Sub-analysis of a Randomized, Double-Blind, Multicenter Phase 3 Study
14天前
已完结
Use of Apremilast in Combination With Other Therapies for Treatment of Chronic Plaque Psoriasis
15天前
已完结
Combination therapy of apremilast and secukinumab in patients with moderate‐to‐severe, recalcitrant plaque psoriasis
15天前
已完结
Combination Therapy with Apremilast and Biologics for Psoriasis: A Systematic Review
15天前
已完结
Characterization and treatment outcomes of biologic therapy in super-responders and biologic-refractory psoriasis patients: A single-center retrospective study in China
16天前
已完结
The impacts of biologic treatment on metabolic profiling in psoriasis
16天前
已完结
Poor early response to methotrexate portends inadequate long-term outcomes in patients with moderate-to-severe psoriasis: Evidence from 2 phase 3 clinical trials
19天前
已完结
皖公网安备34019202002308
